A NOVEL FUNCTIONAL CLASSIFICATION OF TP53 GERMLINE VARIANTS: CAN THIS INFORM CANCER SCREENING PRACTICES IN YOUNG CHILDREN?

被引：0
|
作者：
Freycon, Claire [1 ,2 ]
Montellier, Emilie [3 ]
Budd, Crystal [1 ]
Blanchet, Sandrine [3 ]
Tachdjian, Melissa [1 ]
Hainaut, Pierre [3 ]
Goudie, Catherine [1 ,2 ]
机构：
[1] McGill Univ, Res Inst, Child Hlth & Human Dev Dept, Hlth Ctr, Montreal, PQ, Canada
[2] McGill Univ, Div Hematol Oncol, Dept Pediat, Hlth Ctr, Montreal, PQ, Canada
[3] Univ Grenoble Alpes, CNRS, Inst Adv Biosci, Inserm 1209, Grenoble, France
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O198
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [41] Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer
    Feng, Yun
    Liu, Hongliang
    Duan, Bensong
    Liu, Zhensheng
    Abbruzzese, James
    Walsh, Kyle M.
    Zhang, Xuefeng
    Wei, Qingyi
    CARCINOGENESIS, 2019, 40 (04) : 521 - 528
  • [42] Novel germline TP53 variant (p.(Phe109Ile)) confer high risk of cancer
    Byrjalsen, Anna
    Stoltze, Ulrik Kristoffer
    Lautrup, Charlotte
    Christensen, Lise Lotte
    Mikkelsen, Torben
    Hjalgrim, Lisa
    Brok, Jesper Sune
    Dahl, Christine
    Schmiegelow, Kjeld
    Borgwardt, Lotte
    Diness, Birgitte Rode
    Hansen, Thomas Van Overeem
    Wadt, Karin A. W.
    JOURNAL OF MEDICAL GENETICS, 2024,
  • [43] Sarcomas in the Dutch LFS population: Data from the national screening of TP53 germline mutation carriers at the Netherlands Cancer Institute
    de Wit, G. F.
    Ruijs, M. W. G.
    Bleiker, E. M. A.
    Kuenen, M. A.
    Van Houdt, W. J.
    Heeres, B. C.
    Sonke, G. S.
    Van der Graaf, W. T. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1119 - S1119
  • [44] Prevalence of germline TP53 p.R337H mutation in Brazilian young breast cancer patients.
    Fortes, Fernanda Paschoal
    Tonhosolo, Renata
    Jbili, Rima
    Santiago, Karina Miranda
    Andrade, Kelvin
    Nobrega, Amanda Franca
    Achatz, Maria Isabel Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations
    Silva, Amanda G.
    Krepischi, Ana C. V.
    Pearson, Peter L.
    Hainaut, Pierre
    Rosenberg, Carla
    Achatz, Maria Isabel
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [46] The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations
    Amanda G Silva
    Ana CV Krepischi
    Peter L Pearson
    Pierre Hainaut
    Carla Rosenberg
    Maria Isabel Achatz
    Orphanet Journal of Rare Diseases, 9
  • [47] Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group
    Diessner, Brandon J.
    Pankratz, Nathan
    Hooten, Anthony J.
    Mirabello, Lisa
    Sarver, Aaron L.
    Mills, Lauren J.
    Malkin, David
    Kelley, Ava C.
    Spector, Logan G.
    JCO PRECISION ONCOLOGY, 2020, 4 : 1187 - 1195
  • [48] New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer
    Castillo-Guardiol, Veronica
    Desamparados Sarabia-Meseguer, M.
    Marin-Vera, Miguel
    Isabel Sanchez-Bermudez, Ana
    Luis Alonso-Romero, Jose
    Antonio Noguera-Velasco, Jose
    Ruiz-Espejo, Francisco
    CANCER GENETICS, 2018, 228 : 1 - 4
  • [49] Adolescent triple-negative breast cancer with germline pathogenic variants in both BRCA1 and TP53 genes: A case report
    Chen, Dongmei
    Zhang, Chenyang
    Yuan, Mengqi
    Zhang, Ying
    Liu, Qing
    Wan, Donggui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study
    Cesar de Andrade, Kelvin
    Khincha, Payal P.
    Hatton, Jessica N.
    Frone, Megan N.
    Wegman-Ostrosky, Talia
    Mai, Phuong L.
    Best, Ana F.
    Savage, Sharon A.
    LANCET ONCOLOGY, 2021, 22 (12): : 1787 - 1798
12345